BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.63 EUR -0.38% Market Closed
Market Cap: 57.5m EUR

Operating Margin
BRAIN Biotech AG

-16.2%
Current
-12%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-16.2%
=
Operating Profit
-8.7m
/
Revenue
53.6m

Operating Margin Across Competitors

No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
57.5m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
3.13 EUR
Undervaluation 16%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-16.2%
=
Operating Profit
-8.7m
/
Revenue
53.6m
What is the Operating Margin of BRAIN Biotech AG?

Based on BRAIN Biotech AG's most recent financial statements, the company has Operating Margin of -16.2%.

Back to Top